ACE2 and infection: A dose-dependent assay was used to determine what concentration of the inhibitor could be used without affecting cell viability in either angiotensin-converting enzyme 2 (ACE2-A549) cells (used in infection assays—Fig. S6A) or HEK-293T cells (used in overexpression analysis—Fig. S6B).